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Abstract 
EXPRESSION OF PROTEINS WITHIN THE NOGO RECEPTOR COMPLEX ARE 
ALTERED IN THE DORSOLATERAL PREFRONTAL CORTEX IN 
SCHIZOPHRENIA 
Andrews, J., Newell, K., Fernandez, F. 
1. Centre for Translational Neuroscience, School of Health Sciences, University of Wollongong, Australia  
2. Schizophrenia Research Institute, Sydney, Australia 
 
Purpose: Schizophrenia is a severe neuropsychiatric disorder with an elusive aetiology, thought to 
result from abnormal brain development.  Nogo is an oligodendrocyte bound molecule that signals by 
binding to its receptor NgR, located on axonal membranes that interacts with its co-receptors p75 or 
TROY and Lingo-1. Nogo signalling is responsible for CNS myelin regulation and neurite outgrowth 
during neurodevelopment, and plasticity in the mature brain. This study examined NgR, p75, TROY 
and Lingo-1 protein levels within the human dorsolateral prefrontal cortex (DLPFC) in schizophrenia.   
Methods: Human DLPFC matched case control samples (n=37/group) from the NSW Brain Bank 
Network were used to assess NgR, p75, TROY and Lingo-1 protein levels by immunoblotting.   
Results: NgR protein expression was significantly decreased by 16% (p<0.001) and Lingo-1 protein 
expression was significantly increased by 12% (p=0.006) in the DLPFC of schizophrenia subjects. 
Interestingly, neither the third receptor in this trimolecular receptor complex p75, nor its 
homolog TROY, showed any significant difference in levels of protein expression in 
schizophrenia subjects compared to controls (p=0.146 and p=0.500 respectively). There was a 
significant correlation between the protein levels of NgR and Lingo-1 (r=-0.276, p=0.017); between 
Lingo-1 and p75 (r=0.263; p=0.023) and between NgR and TROY (r=0.329; p=0.004).  
Conclusion: This study shows strong evidence for the involvement of NgR/p75/Lingo-1 or 
NgR/TROY/Lingo-1 complex in schizophrenia, however further studies are required in order to 
investigate the implications of these proteomic alterations to the aetiology and symptomatology of 
schizophrenia. 
